Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
introduction of autologous engineered chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 7
Introduce Autolog CAR T in Central Vein, Perc, New Tech 7
introduce autolog car t in central vein, perc, new tech 7